A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

Ir-Vax is under clinical development by ImmunoRestoration and currently in Phase I for Triple-Negative Breast Cancer (TNBC).

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

A breast cancer diagnosis is almost always followed by invasive biopsies, surgery, radiotherapy, chemotherapy and hormone ...

At this purportedly joyous time of the year — although for many people it is not — there is reluctance to focus on topics perceived to be troubling, especially health topics that have a potentially ...

Women with Stage 0 breast cancer who got biannual mammograms and delayed surgery for two years fared as well as those who got immediate surgery.

Two-year cumulative rate of invasive ipsilateral breast cancer was 5.9 and 4.2% for guideline-concordant care, active monitoring HealthDay News — For patients with ductal carcinoma in situ (DCIS), ...

San Antonio Breast Cancer Symposium was held from Dec. 10 to 13 in San Antonio. Attendees included medical oncologists, radiation oncologists, researchers, and other health care professionals. The ...

Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma; HCC), gall bladder, and bile ducts (collectively called biliary tract cancers). The most ...

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...

Casdozokitug is a novel IL-27 antagonistic antibody being evaluated in two ongoing clinical studies: a Phase 1/2 study in advanced solid tumors and a Phase 2 study in hepatocellular carcinoma.

Another in the Journal of the American Medical Association suggests a new approach to a type of breast cancer called ductal carcinoma in situ, or DCIS. Every year, about 50,000 women in the U.S. are ...